These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
757 related items for PubMed ID: 9602476
1. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA. Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [Abstract] [Full Text] [Related]
2. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD, McIntosh SF, Halstead AC. Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [Abstract] [Full Text] [Related]
3. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL. Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701 [Abstract] [Full Text] [Related]
8. Triploidy identified through second-trimester serum screening. Huang T, Alberman E, Wald N, Summers AM. Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661 [Abstract] [Full Text] [Related]
9. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype]. Dimitrova V, Chernev T, Vragaleva S, Slŭncheva B, Mikhaĭlova E, Kremenski I, Simeonov E. Akush Ginekol (Sofiia); 2002 Mar; 41(6):3-12. PubMed ID: 12577497 [Abstract] [Full Text] [Related]
11. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay. Talbot JA, Spencer K, Abushoufa RA. Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803 [Abstract] [Full Text] [Related]
16. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC, Canda MT, Ahmet N, Arda S, Süt N, Varol FG. Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [Abstract] [Full Text] [Related]
17. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK. J Matern Fetal Med; 1996 Jan; 5(2):70-3. PubMed ID: 8796771 [Abstract] [Full Text] [Related]
18. The detection of non-immune hydrops through second-trimester maternal serum screening. Saller DN, Canick JA, Oyer CE. Prenat Diagn; 1996 May; 16(5):431-5. PubMed ID: 8844001 [Abstract] [Full Text] [Related]
19. Effect of gravidity on maternal serum markers for Down's syndrome. Barkai G, Goldman B, Ries L, Chaki R, Cuckle H. Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805 [Abstract] [Full Text] [Related]